Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Therapeutics and Prevention

Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis

I. L. Bartek, M. J. Reichlen, R. W. Honaker, R. L. Leistikow, E. T. Clambey, M. S. Scobey, A. B. Hinds, S. E. Born, C. R. Covey, M. J. Schurr, A. J. Lenaerts, M. I. Voskuil
Patricia A. Bradford, Editor
I. L. Bartek
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. Reichlen
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. W. Honaker
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. L. Leistikow
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. T. Clambey
bDepartment of Anesthesiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. S. Scobey
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. B. Hinds
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. E. Born
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. R. Covey
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. Schurr
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. J. Lenaerts
cMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. I. Voskuil
aDepartment of Immunology and Microbiology, University of Colorado—Denver, School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia A. Bradford
Antimicrobial Development Specialists, LLC
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00176-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Antibiotics target specific biosynthetic processes essential for bacterial growth. It is intriguing that several commonalities connect the bactericidal activity of seemingly disparate antibiotics, such as the numerous conditions that confer broad-spectrum antibiotic tolerance. Whether antibiotics kill in a manner unique to their specific targets or by a universal mechanism is a critical and contested subject. Herein, we demonstrate that the bactericidal activity of diverse antibiotics against Mycobacterium smegmatis and four evolutionarily divergent bacterial pathogens was blocked by conditions that worked to maintain intracellular pH homeostasis. Single-cell pH analysis demonstrated that antibiotics increased the cytosolic pH of M. smegmatis, while conditions that promoted proton entry into the cytosol prevented intracellular alkalization and antibiotic killing. These findings led to a hypothesis that posits antibiotic lethality occurs when antibiotics obstruct ATP-consuming biosynthetic processes while metabolically driven proton efflux is sustained despite the loss of proton influx via ATP synthase. Consequently, without a concomitant reduction in respiratory proton efflux, cell death occurs due to intracellular alkalization. Our findings indicate the effects of antibiotics on pH homeostasis should be considered a potential mechanism contributing to antibiotic lethality.

IMPORTANCE Since the discovery of antibiotics, mortality due to bacterial infection has decreased dramatically. However, infections from difficult to treat bacteria such as Mycobacterium tuberculosis and multidrug-resistant pathogens have been on the rise. An understanding of the cascade of events that leads to cell death downstream of specific drug-target interactions is not well understood. We have discovered that killing by several classes of antibiotics was stopped by maintaining pH balance within the bacterial cell, consistent with a shared mechanism of antibiotic killing. Our findings suggest a mechanism of antibiotic killing that stems from the antibiotic’s ability to increase the pH within bacterial cells by disrupting proton entry without affecting proton pumping out of cells. Knowledge of the core mechanism necessary for antibiotic killing could have a significant impact on the development of new lethal antibiotics and for the treatment of recalcitrant and drug-resistant pathogens.

INTRODUCTION

Antibiotics target biosynthetic processes essential for cell growth. Inhibition of nucleic acid, protein, or cell wall synthesis leads to cessation of growth and often cell death. However, why some drugs kill while others are bacteriostatic is not well understood. Additionally, the specific downstream effects of the primary drug-target interaction that ultimately cause bacterial death have yet to be elucidated. Multiple commonalities exist between the bactericidal activities of seemingly disparate antibiotic targets. These include the existence of generalized persister populations that are simultaneously tolerant to multiple antibiotics as well as specific metabolic conditions that confer broad-spectrum antibiotic tolerance, particularly those that inhibit respiration (1–8). The existence of these commonalities has led to the hypothesis that antibiotics share a mechanism of bactericidal activity (3, 11).

Although the exact mechanism of antibiotic cell death is unclear, it appears that cellular metabolism plays a key role. Cellular processes involved in metabolism, growth, division, and maintaining energy balance are multifaceted and numerous. Cellular respiration in its simplest form can be described as a series of metabolic reactions used to break down nutrients in order to provide biochemical energy in the form of ATP. Electron carriers such as NADH feed electrons from catabolic reactions to electron transport systems, which translocate protons across the inner cytoplasmic membrane, forming a proton gradient. Energy from the proton gradient is harnessed via ATP synthase as protons flow back into the cell (10). Vast amounts of ATP are then hydrolyzed during biosynthetic processes such as nucleic acid, protein, and cell wall synthesis. It is well established that slowing respiration will result in general antibiotic tolerance (3–5, 11–13). More broadly, conditions that increase tolerance to antibiotics appear to have one commonality: a decreased capacity for proton translocation. Inhibition of cytochrome oxidase or other respiratory components will result in reduced electron flow through the electron transport system (ETS), directly reducing mechanisms for pH gradient generation (4, 5, 13–15). Metabolic manipulations may also affect proton translocation indirectly through actions on pathways that in turn decrease turnover of NADH or other mechanisms that donate electrons to the ETS (3, 6, 11).

We propose a model in which an imbalance in proton homeostasis, resulting in a decrease in intracellular proton concentration, is at least partially responsible for antibiotic-induced cell death. The majority of protons that reenter the cell do so through ATP synthase (10, 14), thus maintaining proton homeostasis. ATP synthesis only occurs if ATP is consumed by biosynthetic processes that recycle ADP. If major ATP-driven biosynthetic processes are inhibited by antibiotic activity, ATP turnover will decrease. A decrease in proton influx coupled with continued or increased proton efflux should cause an increase in intracellular pH (pHIN), which if substantial enough could result in bacterial membrane disruption.

We challenged Gram-positive, Gram-negative, and acid-fast bacteria with multiple classes of antibiotics to study the role of proton homeostasis in antibiotic-induced cell death. We demonstrated that antibiotic-induced death was abrogated by conditions that lowered pHIN and was exacerbated under conditions in which pHIN increased. Using flow cytometry for single-cell analysis of Mycobacterium smegmatis, pHIN was observed to increase after antibiotic exposure but not in the presence of a protonophore, which decreased pHIN and rescued antibiotic killing. The observed decrease in antibiotic killing resulting from manipulation of pH homeostasis did not appear to be a result of a general disruption of metabolic processes or decreased antibiotic activity against specific antibiotic targets.

RESULTS

Protonophore activity and acidic extracellular pH prevented chlorpromazine lethality.The concept of proton homeostasis as an important aspect of antibiotic killing grew from our investigation of chlorpromazine. Chlorpromazine is a phenothiazine that is bactericidal against mycobacteria and has been shown to inhibit the essential respiratory enzyme Ndh, a type II NADH dehydrogenase (Ndh2) (16). The functional difference between Ndh2 and Ndh1 resides in the fact that Ndh1 is energy conserving and pumps four protons, while Ndh2 is unable to translocate protons (17). Thus, we predicted inhibition of Ndh2 should disrupt proton homeostasis by shifting NADH oxidation toward proton-translocating alternatives to Ndh2. To determine if the activity of chlorpromazine was dependent on excess proton translocation, a subinhibitory dose of the protonophore 2,4-dinitrophenol (DNP) was added to facilitate proton equalization across the membrane gradient. DNP levels were first titrated against M. smegmatis to determine a concentration that did not inhibit growth (Fig. 1). Use of a subinhibitory DNP dose ensured the effect of the protonophore was not a result of pH gradient dissipation and growth arrest. The bactericidal activity of chlorpromazine was entirely abrogated by protonophore addition but not by addition of vehicle, dimethyl sulfoxide (DMSO) (Fig. 1). A subinhibitory dose of a second protonophore, carbonyl cyanide m-chlorophenyl hydrazine (CCCP), also blocked antibiotic killing in a similar manner to DNP (Fig. 1). These findings indicate that the lethal effect of chlorpromazine could be from a hyperpolarized pH gradient and back-pressure on the ETS, or from a depletion of internal protons.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1 Conditions that countered intracellular alkalization increased M. smegmatis antibiotic tolerance.

M. smegmatis was challenged with antibiotics over a pH range or in combination with DNP, CCCP, or DCCD at pH 6.6. Antibiotics were assayed in the presence of DMSO or methanol to control for vehicle effects. Antibiotics were administered at the concentrations listed in Table 3, and CFU were determined at 0 h (no pattern), 3 h (checkered), 12 h (gridded), 24 h (diagonal up), and 48 h (latticed). The data shown are means ± standard deviations from at least 3 replicates. All conditions were compared to the respective pH 6.6 time point for statistical t test analysis (*, P < 0.05; **, P < 0.01).

To distinguish between potential chlorpromazine mechanisms, killing was assayed over a range of extracellular pHs (pHEX). We found an alkaline extracellular environment enhanced chlorpromazine killing, while an acidic environment blocked lethality (Fig. 1). Thus, increasing extracellular protons prevented chlorpromazine killing, thereby demonstrating a hyperpolarized membrane was not the basis for cell death. The increased lethality by alkaline pressure on the bacilli suggested death from chlorpromazine treatment stemmed from depletion of cytoplasmic protons. As pHEX influences pHIN (18, 19), high pHEX should exacerbate antibiotic-induced internal alkalization. Furthermore, changes in pHEX and DNP had no effect on the MIC of chlorpromazine (Table 1). Therefore, increasing proton influx decreased chlorpromazine killing but did not reduce its growth inhibitory activity, demonstrating the antibiotic was active in the presence of the protonophore.

View this table:
  • View inline
  • View popup
TABLE 1

Antibiotic MIC values in this study

Manipulation of pH homeostasis blocked lethality of several classes of antibiotics.Antibiotics that target M. smegmatis DNA, RNA, and protein synthesis were assayed to explore a role in pH homeostasis for drugs that do not directly target proton translocation pathways (Fig. 1). Surprisingly, the lethality of these antibiotics was also blocked with addition of DNP, and all antibiotics demonstrated reduced killing at lower pHEX, while displaying greater killing at higher pHEX. When over 10-fold additional norfloxacin was added to M. smegmatis culture, rescue was achieved through addition of an increased dose of DNP (Fig. 2A). The rescue of norfloxacin killing by DNP was directly proportional to the DNP concentration (Fig. 2B). These results suggest that the disruption of pH homeostasis may be a common attribute of antibiotic bactericidal activity in M. smegmatis.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2 The protonophore concentration required for rescue was proportional to the antibiotic concentration.

(A) M. smegmatis cultures were grown in the presence of 32 µg/ml norfloxacin (4× the calculated MBC) both with and without 5 mM DNP. CFU were determined at 0 h (no pattern), 12 h (gridded), and 24 h (diagonal up). (B) A second set of cultures were exposed to 6 µg/ml norfloxacin across a range of DNP concentrations, and CFU were determined after 24 h of exposure. For statistical analysis on panel A, a t test was used. For statistical analysis on panel B, a Pearson’s correlation coefficient was determined (***, P < 0.001).

Manipulation of pH homeostasis blocked killing but not bacteriostatic activity.To determine if changes in environmental pH or protonophore activity affected the overall mechanism of action of the antibiotics, we determined the MIC of each antibiotic under the conditions utilized for the killing assays (Table 1). An acidic pHEX reduced antibiotic killing of M. smegmatis but had no effect on the MIC for chlorpromazine and kanamycin and decreased the MIC of rifampin from 25 µg/ml to 6.3 µg/ml. Only for norfloxacin did the MIC increase from 2 to 4 µg/ml with acidic pHEX. Addition of a protonophore, which blocked antibiotic killing, did not increase the MIC for any of the four antibiotics. These findings indicate the loss of bactericidal activity was not a result of the inability of antibiotics to inhibit their primary targets as they maintained the ability to stop growth.

To determine if acidic conditions destabilized antibiotics, antibiotics were preincubated for 24 h at each pH, and killing assays were repeated after each pH was adjusted to the standard pH (Fig. 3). Preincubation of antibiotics at pH 5.6, 6.6, or 7.6 had little differential effect on antibiotic activity. Acidic conditions did not appreciably decrease antibiotic activity over the standard pH for any of the four antibiotics. Alkaline pH moderately decreased chlorpromazine and kanamycin activity, while rifampin was slightly more stable at alkaline pH compared to pHs 5.6 and 6.6. These findings are in agreement with the MIC data that demonstrated antibiotic bacteriostatic activity remained intact at low pH.

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3 Loss of antibiotic lethality in acidic pH was not due to antibiotic degradation.

Antibiotics were preincubated for 24 h at 37°C in DTA medium at pHs 5.6, 6.6, and 7.6. The pH was then adjusted to 6.6, and M. smegmatis was added to assay the drug efficacy post-drug incubation at each pH. The data shown are means ± standard deviations.

Intracellular pH increased with antibiotics and decreased with protonophore. M. smegmatis pHIN was measured directly by flow cytometry using a pH-sensitive green fluorescent protein (GFP) (20). Direct pHIN measurements demonstrated that 1.0 mM DNP had only a modest effect on pHIN. Even addition of 4-fold additional DNP failed to fully dissipate the pH gradient (see Fig. 11B and C). In contrast, the protonophore CCCP was highly effective at dissipating the pH gradient and was used to calibrate the GFP ratiometric signal (see Fig. 11A). pHIN of the overall population rose from 7.7 to 8.1 and 8.2 for kanamycin, norfloxacin, and chlorpromazine, but not rifampin (Fig. 4A).

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4 Single-cell flow cytometry analysis of pHIN.

Cultures of M. smegmatis containing a ratiometric pH-sensitive GFP (20) were exposed to antibiotics (Cpz, chlorpromazine; Kan, kanamycin; Rif, rifampin; Nor, norfloxacin) with or without DNP, and individual cells were analyzed by flow cytometry. (A) The average pHIN of the entire M. smegmatis population was determined as described previously (46). (B) Number of cells in the high-pH-gated population (pH of >8.6 [gate 1]) after cells were counted based on ratiometric fluorescence intensities. Samples were compared to the untreated control for statistical t test analysis (*, P < 0.05; **, P < 0.01; ***, P < 0.001).

Unlike other drugs used against M. smegmatis, rifampin was unique in having an extremely high MBC/MIC ratio. While the MIC for rifampin was 25 µg/ml (Table 1), the MBC (minimum bactericidal concentration necessary to decrease CFU by 99.9%) was never observed even at concentrations as high as 1,600 µg/ml. Due to this extreme MBC/MIC ratio, rifampin is considered bacteriostatic against M. smegmatis (as defined by an MBC/MIC ratio of >4) (Table 1; Fig. 1) (21). In order to examine the killing activity of rifampin, a high concentration was used in this study (800 µg/ml) to achieve lethal levels (~99% decrease in CFU after 48 h).

Single-cell flow cytometry analysis demonstrated that 3 h of antibiotic exposure alkalized a subpopulation of bacilli (Fig. 4B). Examination of the subpopulation with a high pHIN (≥8.6) demonstrated that all antibiotics, including rifampin, increased the number of bacilli within this high-pHIN population. Addition of protonophore mitigated the alkalization caused by all antibiotics (Fig. 4). These findings suggest that upon antibiotic challenge, the bulk of the population resisted internal alkalization. However, over time, mechanisms used to resist alkalization failed, resulting in an unsustainable increase in pHIN and subsequent cell death in this affected subpopulation. A large uniform increase in pHIN was not observed—perhaps because a population-wide rise would likely result in a narrow temporal window of drug killing instead of the progressive bacterial death observed during antibiotic exposure.

Proportion of cells in the high-pH populations correlated with antibiotic killing kinetics.Only a small proportion of cells displayed a high pHIN after 1 h of antibiotic exposure (Fig. 4B), which would be expected as only a small percentage of bacilli neared death at 1 h. As each antibiotic caused a different proportion of cells to alkalize internally, and each antibiotic displayed different killing kinetics, we plotted the percentage of survival of each antibiotic after 24 h of exposure to the percentage of cells observed within the high-pH population. A correlation between the percentage of killing and the percentage of cells in the high-pH-gated population was observed (R2 = 0.752) (Fig. 5A). Rifampin was then removed from analysis due to the role of rifampin efflux pumps in M. smegmatis (22–24), which shift rifampin to a bacteriostatic antibiotic except at very high concentration. In the absence of the rifampin data, the correlation coefficient increased (R2 = 0.999) (Fig. 5B). The trend indicates that antibiotics that were more efficient at intracellular alkalization also demonstrated faster killing kinetics.

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5 The rate of antibiotic killing was directly proportional to the efficiency of intracellular alkalization.

(A) The percentage of survival was calculated for each antibiotic used with M. smegmatis (Fig. 1) at the 24-h time point. This was plotted against the proportion of cells observed in the high-pH population (Fig. 2), and a trend line was calculated with a Pearson’s correlation coefficient of R2 = 0.752. Kan, kanamycin; Rif, rifampin; Cpz, chlorpromazine; Nor, norfloxacin. (B) The same analysis was performed excluding rifampin, and a trend line was calculated with a Pearson’s correlation coefficient of R2 = 0.999.

Intracellular alkalization results in cell death.To investigate whether intracellular alkalization alone could cause death, M. smegmatis was exposed to phosphate citrate buffer at a pH near the pHIN, at 1 and 2 U higher or 1 U lower than the pHIN, and in the presence of the protonophores DNP and CCCP. Exposure of cells to a pH 1 U higher than the pHIN led to an ~10-fold greater drop in viability than exposure to a pHEX 1 U lower than the pHIN (Fig. 6). Additionally, lethality was increased in the presence of either DNP or CCCP at pHs 8.6 and 9.6, but not at pH 7.6 or 6.6, further suggesting that intracellular alkalization could contribute to bacterial death observed during antibiotic treatment.

FIG 6
  • Open in new tab
  • Download powerpoint
FIG 6 Alkalization alone caused cell death.

M. smegmatis was exposed to an pHEX of 6.6, 7.6, 8.6, or 9.6 with or without the protonophores DNP and CCCP, and samples were plated at 0 h (no pattern), 24 h (diagonal up), and 48 h (latticed). A t test was used for statistical analyses, and all conditions were compared to the same time point at pH 7.6 (approximate pHIN).

Antibiotic killing was countered through acidification pressure on the pHIN of diverse bacterial pathogens.To test whether the observed pH homeostatic phenomenon was specifically a characteristic of M. smegmatis or potentially a more general characteristic of bactericidal antibiotics, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Mycobacterium tuberculosis were subjected to drug treatments similar to those used for M. smegmatis. Antibiotics and antibiotic concentrations for E. coli and S. aureus were chosen based on a previously published study (3), and concentrations were determined for P. aeruginosa and M. tuberculosis that killed moderately at the neutral pH (~100 to 1,000-fold drop in CFU). A DNP concentration was determined for each species that did not affect growth and was used to ensure that growth arrest was not the basis of rescue (Fig. 7). As was the case for M. smegmatis, DNP inhibited killing from multiple antibiotics used against Gram-negative, Gram-positive, and acid-fast pathogens (Fig. 7). In most cases, the protonophore entirely abolished drug killing even though the drugs remained bacteriostatic (Fig. 7; Table 1). As found for M. smegmatis, a moderate decrease in pHEX decreased antibiotic lethality, while a comparable increase in pHEX increased lethality.

FIG 7
  • Open in new tab
  • Download powerpoint
FIG 7 Shifting pH homeostasis toward intracellular acidification inhibited antibiotic killing of Gram-negative, Gram-positive, and acid-fast pathogens.

S. aureus, E. coli, P. aeruginosa, and M. tuberculosis were challenged with antibiotics at concentrations listed in Table 3 over a pH range or at the mid-pH in combination with DNP. CFU were determined at 0 h (no pattern), 30 min (brick), 1.5 h (diagonal down), 3 h (checkered), 12 h (gridded), 24 h (diagonal up), and 72 h (light horizontal). A t test was used for statistical analysis, and all conditions were compared to the same time point at the standard mid-pH (*, P < 0.05; **, P < 0.01; ***, P < 0.001).

Acidification pressure countered antibiotic killing under anoxic conditions.To ensure that the effect of pH homeostasis on antibiotic killing was not purely an aerobic phenomenon mediated via oxidative stress, anoxic, nitrate-respiring E. coli cultures were exposed to antibiotics in media of different pHs or in the presence of protonophore. As with aerobic cultures, both the acidic environment and the protonophore abrogated killing by antibiotics (Fig. 8). Nitrate addition ensured an active ETS; therefore, it is yet to be determined if pH homeostatic mechanisms could be involved in drug killing under fermentative conditions.

FIG 8
  • Open in new tab
  • Download powerpoint
FIG 8 Anoxic antibiotic killing was inhibited by conditions that promoted intracellular acidification.

Antibiotics (listed in Table 3) were added to anoxic cultures of E. coli in the presence or absence of DNP. CFU were determined at 0 h (no pattern), 3 h (checkered), or 6 h (heavy horizontal) for plating to determine survival by CFU. Kanamycin, an aminoglycoside, did not readily kill E. coli as a strong ΔΨ is required for aminoglycoside uptake (25). A t test was used for statistical analysis, and survival under each condition was compared to that at the same time point at pH 7 (*, P < 0.05; **, P < 0.01).

Antibiotic uptake and bacteriostatic activity were not significantly affected by low pHEX or protonophore activity.To test whether the observed phenomenon was simply an artifact of internal antibiotic concentration, 3H-labeled antibiotics were added to E. coli, S. aureus, P. aeruginosa, and M. smegmatis cultures in media with different pHs or in the presence of protonophore. Internal antibiotic concentrations were then calculated. We observed no statistical reduction in intracellular antibiotic levels either at acidic pHEX or after addition of DNP, indicating lower drug uptake or retention was not likely responsible for the lack of antibiotic killing (Fig. 9). Uptake of kanamycin and gentamicin was not assayed as aminoglycoside antibiotics require a chemiosmotic gradient, or ΔΨ, which is a component of the total proton motive force (PMF [PMF = ΔΨ + ZpH]) for drug entry (25). Thus, the effect of DNP and low pHEX on killing should have been at least partly due to reduced drug uptake for aminoglycoside antibiotics. A decrease in PMF by addition of DNP or acidic pHEX should increase or have no effect on the intracellular concentration of most other drugs as a decrease in PMF reduces PMF-powered efflux pump activity necessary for drug removal from the cytosol (26–28).

FIG 9
  • Open in new tab
  • Download powerpoint
FIG 9 Antibiotic uptake was not decreased by acidic pHEX or protonophore.

[3H]norfloxacin (Nor) was added to the M. smegmatis, E. coli, or S. aureus culture, [3H]vancomycin (Vanc) was added to the S. aureus culture, and [3H]tetracycline (Tet) was added to the P. aeruginosa culture, and intracellular antibiotic concentrations were determined over time. The amount of added antibiotic was normalized to the intracellular protein concentration. For E. coli, S. aureus, and P. aeruginosa, pH 6 is in pink, pH 7 is in white, pH 8 is in blue, and pH 7 with DNP is in yellow. For M. smegmatis, pH 5.6 is in pink, pH 6.6 is in white, pH 7.6 is in blue, and pH 6.6 with DNP is in yellow. For statistical t test analyses, each condition was compared to the same time point at the mid-pH (*, P < 0.05; **, P < 0.01; ***, P < 0.001).

To determine whether antibiotic activity was altered under low pH or in the presence of protonophore, MICs for all antibiotics were determined for P. aeruginosa, E. coli, andS. aureus under all conditions tested. As was observed in M. smegmatis, DNP and low pHEX had little to no effect and sometimes lowered the MIC of antibiotics, indicating that the antibiotics were effective against their targets, even when bactericidal activity was blocked (Table 1).

ATP levels increased with antibiotic treatment and decreased with inhibition of ATP synthase.DNP rescues E. coli from killing by gyrase inhibitors, which was postulated to be due to the decrease in cellular ATP pool (29). We therefore determined whether ATP levels decreased in M. smegmatis when treated with antibiotics and DNP or the ATPase disruptor N,N′-dicyclohexyl carbodiimide (DCCD). ATP levels in antibiotic-treated M. smegmatis cultures were the same as or higher than those in the negative control (Table 2). ATP levels decreased slightly (less than 28%) when DNP was added in three of the antibiotic-treated cultures and increased with one antibiotic, reaching cellular ATP levels 2.4 times that of untreated bacteria. In addition, DCCD increased antibiotic bactericidal activity (Fig. 1), while it drastically reduced the levels of cellular ATP, indicating a decrease in ATP (Table 2) does not account for the loss of antibiotic killing.

View this table:
  • View inline
  • View popup
TABLE 2

Measurement of intracellular ATP in M. smegmatis

DISCUSSION

Generation of an energized membrane by proton translocation is a primary output of energy metabolism and is required for many forms of life. We propose a model in which antibiotics kill bacteria, at least in part, through disruption of major cellular biosynthetic processes, which in turn drives an imbalance in proton homeostasis leading to lethal changes in pHIN (Fig. 10). In this model, antibiotic disruption of DNA, RNA, protein, or cell wall biosynthesis subsequently decreases ATP consumption from all biosynthetic cellular processes due to an overall cessation of growth, resulting in a global reduction in ATP turnover. Indeed, bacterial cells exposed to bactericidal antibiotics display an increase in cytosolic ATP levels (30–32). We also confirmed that ATP levels increased upon antibiotic exposure. However, in our model the decrease in flux through the ATP synthase is of greater importance than the absolute level of ATP per se. In the absence of a concomitant reduction in respiration during the loss of ATP synthesis, protons would be drained from the cytosol and not replaced via ATP synthesis. The pH homeostatic hypothesis proposes that in order to determine if an antibiotic is subinhibitory, bacteriostatic, or bactericidal, all factors that affect pHIN need to be considered. These include not only the overall inhibitory activity of the antibiotic on its target but also respiration rate, countermeasures employed to maintain pH homeostasis, the effects of drug influx and efflux on pHIN and many other factors that influence the concentration of intracellular protons which may be specific to each bacterial species.

FIG 10
  • Open in new tab
  • Download powerpoint
FIG 10 pH homeostatic hypothesis of antibiotic lethality.

In the absence of antibiotics, nutrient-replete conditions sustain reduction of electron carriers and drive proton translocation via the ETS. Protons return to the cytosol through ATP synthesis. Bactericidal antibiotics target ATP-consuming reactions in a manner that fails to coordinately reduce the rate of proton translocation. Intracellular alkalization follows as the rate of ATP synthesis abates from an overall reduction in all biosynthetic reactions. Bacteria die as countermeasures to intracellular alkalization fail and pHIN increases beyond viable limits.

Herein we show that antibiotics directly caused an increase in M. smegmatis pHIN and pushed a subset of the population to alkalize internally. The percentage of the population that alkalized after antibiotic stress was directly proportional to the rate at which each antibiotic killed. Conditions that promoted proton influx, such as a low pHEX or the addition of a protonophore, caused antibiotic tolerance, whereas conditions that reduced proton influx, such as a high pHEX caused an increase in antibiotic sensitivity. We also demonstrated that an increase in pHIN was highly lethal, even in the absence of antibiotics.

The proton homeostatic hypothesis predicts that a key aspect of bactericidal antibiotics is a decrease in ATP flux in the absence of triggering a reduction in proton translocation. Bacteria have a variety of mechanisms to maintain proton homeostasis when facing alkalization pressure (33); however, if these mechanisms and proton reentry from ATP synthesis are outpaced by proton pumping, pHIN will eventually alkalize to a point where hydrogen bonds between membrane lipids become disrupted or other essential processes collapse. Indeed, alkaliphiles synthesize high levels of cardiolipins, potentially to trap protons at the membrane surface in order to prevent membrane disruption in the face of severe environmental proton deficiency (33). In further support of the proton homeostatic hypothesis, antibiotic treatment increased ATP levels, and low doses of the ATP synthase inhibitor were synergistic with the killing activity of antibiotics. Additionally, we found that DNP was capable of inhibiting antibiotic killing under anoxic conditions, indicating the proton homeostatic hypothesis could account for antibiotic lethality in the absence of oxidative stress. However, additional experiments will be required to establish if pH homeostatic mechanisms influence bactericidal activity under fermentative conditions, during which the ATP synthase often runs in reverse, using ATP to pump protons across the bacterial inner membrane.

DNP was used at concentrations that did not affect cell growth rate to reduce the possibility that DNP induced tolerance due to growth arrest. Furthermore, a second protonophore, CCCP, also inhibited the bactericidal activity of antibiotics, indicating that specific pleiotropic effects of DNP were also not likely responsible for countering antibiotic killing. It could be argued that addition of DNP decreased intracellular ATP, which in turn decreased antibiotic target activity, thus affecting antibiotic killing. However, the DNP concentrations used in this study did not collapse the proton gradient, and DNP caused only a minor reduction in cellular ATP levels with three of the four antibiotics, and in one case, cellular ATP levels were more than double those of the untreated control. Furthermore, an additive effect was observed for all antibiotics in the presence of an ATPase inhibitor, which caused a far more dramatic drop in ATP than any protonophore-antibiotic combination. DCCD prevents ATP synthesis by blocking proton flow into the cell (9, 34, 35), which the proton homeostatic model predicts should exacerbate antibiotic killing by decreasing proton influx. Together, these results indicate that a decrease in ATP does not likely account for the rescue of antibiotic killing provided by DNP.

Flow cytometry demonstrated that all antibiotics tested, with the exception of rifampin, caused an overall average increase in pHIN of the population. Although lethal levels of rifampin did increase the subpopulation of bacilli in an alkaline state, M. smegmatis is incredibly resistant to rifampin, with an MBC/MIC ratio over 84, well above the ratio in which antibiotics are considered bacteriostatic (21). Increased resistance of M. smegmatis to rifampin is due to LfrA and EfpA, members of the proton antiporter family (24, 36). The proton influx used to expel rifampin not only results in high rifampin resistance, but would be expected to contribute to a decrease in pHIN from the influx of protons to drive the efflux pumps. As most antibiotic efflux pumps are either proton antiporters or hydrolyze ATP in order to function (22, 23), the effectiveness of these efflux pumps in preventing killing may be partially due to a role in decreasing pHIN. Although rifampin functions primarily as a static drug in M. smegmatis, a high dose was used to obtain lethality in this study to isolate the effects of pH on bactericidal antibiotic activity. ATP levels increased 2.3-fold after rifampin exposure, while exposure to the three bactericidal antibiotics modestly raised ATP levels (<20%). Since the level of rifampin was 84 times higher than the MIC necessary to stop growth, it is likely that all rifampin RNA polymerase targets were saturated, resulting in maximum decrease in ATP utilization. In addition, the expected population-wide increase in pHIN from loss of ATP flux could have been largely offset from proton influx in exchange for rifampin efflux. However, the subpopulation increase with an alkaline pHIN at lethal levels of rifampin indicated that a fraction of the population lost the ability to maintain pH homeostasis, resulting in death. These differences between rifampin and the three bactericidal antibiotics may indicate fundamental differences in bacteriostatic and bactericidal antibiotics. It was recently reported that bactericidal antibiotics accelerate respiration, while bacteriostatic drugs either suppress or have no effect on respiration (3, 37). It has been shown that the bacteriostatic antibiotic chloramphenicol targets the 50S ribosome subunit, but also decreases respiration by an unknown mechanism (38). The mechanisms involved in increasing or decreasing respiration by bactericidal versus bacteriostatic antibiotics are not well understood. However, the finding that the rate of respiration influences whether an antibiotic is lethal supports the importance of proton-translocating pathways in antibiotic killing.

As antibiotics kill a population slowly over time, rather than causing immediate sterilization, one would expect only a small proportion of the population at any point in time to display an alkaline cytosol. This is in fact what was observed when we measured pHIN of individual cells. Additionally, it could be predicted that antibiotics with faster killing kinetics would cause a larger proportion of a population to alkalize. This phenomenon was observed with a strong correlation between the rate of bactericidal antibiotic killing and the proportion of cells with an alkaline cytosol.

It has been postulated that antibiotics have a common bactericidal mechanism that emanates from the production of oxidative stress generated from increased aerobic respiration (3, 11, 39). Kohanski et al. demonstrated that the antioxidant thiourea and the iron chelator 2,2′-dipyridyl blocked killing by antibiotics (3, 11). The dye hydroxyphenol fluorescein (HPF) was used as a hydroxyl radical intracellular probe that indicated an increase in oxidative stress during antibiotic killing (3). Two subsequent studies questioned the oxidative stress hypothesis, pointing to the fact that antibiotics are bactericidal in the absence of oxygen (40, 41). It was also demonstrated that thiourea protects anaerobic respiring bacteria from antibiotic killing (41). We propose that the ability of antioxidants like thiourea and iron chelators to suppress respiration (42, 43), and thus proton translocation, may be the basis of their protection against antibiotic killing rather than oxidative stress per se. In addition, HPF is also known to function as a pH sensor, and HPF demonstrated a shift under anaerobic conditions in absorbance after antibiotic challenge, consistent with an increase in pHIN (41, 44), further supporting cytosol alkalization in antibiotic-treated cells. Hydrogen sulfide and nitric oxide have also been shown to rescue antibiotic lethality (4, 5). Importantly, these gases are powerful inhibitors of aerobic respiration via binding to cytochrome oxidase (15) and thus will dramatically reduce aerobic proton translocation. In addition, respiratory enzyme mutants confer antibiotic tolerance, especially those that result in a ratio shift in protons pumped per electron traversing the ETS (37, 39, 45). The chemistries of electrons and protons are closely linked, which makes it difficult to decipher if effects are due to oxidative stress or disruption of pH homeostasis. The pH homeostatic hypothesis is consistent with many of the experimental findings that suggest antibiotics kill via oxidative stress and with the compelling arguments that have questioned the role of oxidative stress as the common factor in the bactericidal activity. The oxidative stress and the pH homeostatic hypotheses of antibiotic killing are not mutually exclusive, and consideration of the effects of pH may explain some deficiencies in the oxidative stress model.

Our experimental evidence suggests a link between antibiotic bactericidal activity and pH homeostasis. However, only a limited number of antibiotics were investigated, and the most compelling experiments indicating antibiotic effects on pHIN were conducted only in M. smegmatis. We also did not investigate the role of pH on antibiotic killing of strict anaerobes or under anaerobic conditions in which nonrespiratory pathways are used to generate a pH gradient. As perturbations of proton homeostasis have global effects on bacterial metabolism, alternative explanations will need to be further investigated to challenge or validate the role of protons in antibiotic killing. The pH homeostatic hypothesis provides a novel framework to view the bactericidal activity of antibiotics that, if correct, could be critical to the interpretation of numerous conditions that influence antibiotic lethality, and to understand mechanisms employed by persisters to tolerate a wide range of antibiotics.

MATERIALS AND METHODS

Culture conditions and strains.Overnight cultures of E. coli MG1655, S. aureus ATCC 25923, and P. aeruginosa PAO1 grown in lysogeny broth Lennox (pH 7) (LB medium) were diluted 1:50 in LB medium at pH 6 (adjusted with hydrochloric acid), 7, or 8 (adjusted with sodium hydroxide) in 125-ml Erlenmeyer flasks. Cultures were allowed to grow while shaking for 1.5 h, and diluted to an optical density at 600 nm (OD600) of 0.1 with LB medium of the same pH. One-milliliter culture aliquots were added to 15-ml snap-cap tubes, antibiotics were added at concentrations listed in Table 3, and samples were incubated at 37°C shaking at 250 rpm. One hundred microliters of each experimental sample was collected at different time points via centrifugation at 16,000 × g for 1 min and suspended in LB medium, and survival was assayed by serial dilution and plating on LB agar plates. For M. smegmatis mc2155, overnight cultures grown in Dubos-Tween-albumin (DTA) medium (Difco Dubos broth base [Becton Dickinson], 0.5% bovine serum albumin fraction V, 0.75% glucose, 0.17% NaCl, 0.05% Tween 80) were diluted to an OD600 of 0.03 in DTA at pH 5.6 (adjusted with hydrochloric acid) or pH 6.6 or 7.6 (both adjusted with sodium hydroxide) and allowed to grow at 37°C in 125-ml Erlenmeyer flasks for 1.5 h while being stirred at 150 rpm. One-milliliter aliquots were added to 15-ml snap-cap tubes, and antibiotics and other drugs were added at the concentrations listed in Table 3. DCCD was added at a final concentration of 500 µM, and CCCP was added at a final concentration of 50 µM for the experiments illustrated in Fig. 1. Cultures were incubated with shaking at 250 rpm at 37°C. One hundred microliters of each experimental sample was collected at different time points via centrifugation at 16,000 × g for 1 min and suspended in DTA medium, and survival was assayed by serial dilution and plating onto DTA agar plates containing 4 g/liter of activated charcoal. Mid-log-phase (OD600 of 0.2 to 0.4) cultures of M. tuberculosis H37Rv grown in DTA medium were diluted in DTA to an OD600 of 0.05 at pH 5.6, 6.6, or 7, and 1-ml aliquots were added to sterile glass tubes (20 by 125 mm) containing stir bars (12 mm by 4.5 mm). Cultures were outgrown 1 h at 37°C, antibiotics were added, and samples were stirred rapidly (200 rpm) using a rotary magnetic tumble stirrer (V and P Scientific, San Diego, CA). Samples were taken at intervals, serially diluted, and plated on DTA agar plates containing 4 g/liter of activated charcoal to determine survival.

View this table:
  • View inline
  • View popup
TABLE 3

Antibiotic concentrations used in this study

To determine the relative stability of antibiotics at pH 5.6, 6.6, and 7.6, each antibiotic was preincubated in DTA medium for 24 h at each pH. The media containing drugs at pHs 5.6 and 7.6 were then adjusted to pH 6.6 followed by filter sterilization. Pelleted M. smegmatis cells were suspended in preincubated DTA containing antibiotic, and the killing assays were conducted as described for the experiments shown in Fig. 1.

For anoxic growth, E. coli MG1655 single colonies were inoculated in 25-ml M9 minimal medium at pH 7 supplemented with 0.2% (wt/vol) succinate and 0.2% (wt/vol) d-lactate in 125-ml Erlenmeyer flasks and grown overnight at 37°C with shaking at 250 rpm. Cultures were diluted 1:50 into 10-ml anoxic M9 minimal medium supplemented with 0.2% (wt/vol) succinate, 0.2% (wt/vol) d-lactate, 400 mM sodium nitrate, and 0.1% (vol/vol) Oxyrase in 16-ml Hungate tubes with a tuberculin syringe through a butyl rubber septum stopper. Cultures were grown at 37°C for 16 h with shaking at 250 rpm, and diluted to an OD600 of 0.01 via the Hungate technique in fresh anoxic M9 medium at pH 6, 7, or 8 supplemented with 0.2% (wt/vol) succinate, 0.2% (wt/vol) d-lactate, 400 mM sodium nitrate and 0.1% (vol/vol) Oxyrase. Cultures were outgrown for 1.5 h, and antibiotics were added via syringe at concentrations listed in Table 3. Select cultures were supplemented with resazurin to ensure complete removal of oxygen. Samples were taken at different time points, and survival was assayed on LB agar plates.

To assay survival in phosphate citrate buffer of different pHs, overnight cultures of M. smegmatis were diluted to an OD600 of 0.05 and subjected to centrifugation, and pellets were suspended in phosphate-citrate buffer at pH 6.6, 7.6, 8.6, or 9.6. One-milliliter aliquots were added to 15-ml snap-cap tubes, and 25 µM CCCP or 1 mM DNP was added. Cultures were grown and survival determined as described above for M. smegmatis.

MIC determination.Overnight cultures were started for E. coli, S. aureus, P. aeruginosa, and M. smegmatis as described above. Bacteria were then exposed to 2-fold dilutions of antibiotics. Samples were plated at time zero and 3 h (for E. coli, S. aureus, and P. aeruginosa) or 24 h (for M. smegmatis). CFU were determined and recorded. The MIC was recorded as the minimum concentration at which the final CFU count was less than twice that at time zero. The values reported represent the mode of 3 biological replicates.

Flow cytometry analysis.Liquid cultures of M. smegmatis containing a plasmid encoding the ratiometric pH-sensitive green fluorescent protein (GFP) described elsewhere (20, 46) were maintained in DTA medium containing hygromycin at 20 µg/ml. Overnight cultures were diluted in fresh DTA without hygromycin to an OD600 of 0.03 and were allowed to grow while being stirred at 150 rpm at 37°C for 1.5 h. Antibiotics with or without DNP were added to cultures at the concentrations listed in Table 3. Cultures were maintained shaking in a 37°C Gyrotory water bath shaker (New Brunswick Scientific) until used for flow cytometry analysis in order to maintain proper culture temperature and aeration. After 3 h of antibiotic exposure, flow cytometry was performed at the CU-Anschutz Medical Campus Cancer Center Flow Core on a Moflo XDP 70 cell sorter. Samples were maintained at 37°C throughout the analysis process. Data were collected on 1 × 105 bacterium-size particles per sample. To place analysis gates, the mean fluorescence intensity ratio was obtained using the untreated control containing the ratiometric GFP. The standard deviation was calculated using Summit5.3 software, and 1.5 standard deviations from the mean in either direction were used to place the “normal” pH gates (gates 2 and 3 in Fig. 11D). Gate 1 (“high pH”) was defined as the gate with a lower fluorescence intensity ratio than gate 2; gate 4 included all cells with a higher fluorescence intensity ratio than gate 3. After all gates were set, cultures were counted, and Summit5.3 software was used to analyze samples. Number of events in the high-pH gate was divided by total counts to determine the proportion in the high-pH gate. Background fluorescence was determined by analyzing M. smegmatis lacking the ratiometric pH-sensitive GFP. For all data analysis, doublet cells were first excluded from samples via side scatter then analysis was restricted to GFP-positive cells. To calculate the pHIN of all samples, a standard curve was generated as described elsewhere (Fig. 11A) (46). Antibiotics were added to samples as described above and analyzed via flow cytometry after 1 h of incubation, also as described. Internal pH values were determined by interpolating 410/470 fluorescence ratios on the standard curve. For average pHIN measurements, each reported value represents the mean and standard deviation from 9 biological replicates for untreated and 8 biological replicates for all other conditions. Each reported high-pH population value represents the mean and standard deviation from 9 biological replicates for untreated, 5 biological replicates for treated with DNP, rifampin, rifampin plus DNP, and kanamycin, 4 biological replicates for treated with chlorpromazine, chlorpromazine plus DNP, and kanamycin plus DNP, and 3 biological replicates for treated with norfloxacin and norfloxacin plus DNP.

FIG 11
  • Open in new tab
  • Download powerpoint
FIG 11 Flow cytometry analysis of DNP effect on proton gradient.

(A) A sigmoidal standard curve was generated in the presence of CCCP similar to that observed previously (46). (B) DNP at 0, 0.5, 1, 2, or 4 mM DNP was added to M. smegmatis culture containing the ratiometric pH-sensitive GFP for 20 min, and cells were subsequently analyzed via flow cytometry. (C) pHIN was calculated from the experiments shown in panel B. Even at the highest dose of 4,000 µM DNP (4-fold higher than the concentration used for M. smegmatis experiments), the pHIN never reached the pHEX of the medium. In contrast, 500 µM CCCP, a much stronger protonophore, equalized pHIN to that of the medium within 20 min. (D) For flow cytometric gate placement, the mean fluorescence ratio of the untreated control and the standard deviation were calculated using Summit5.3 software. Gate 2 was set as the mean − 1.5 standard deviations from the mean. Gate 3 encompassed the mean + 1.5 standard deviations from the mean. Gate 1 included all cells with a lower fluorescence intensity ratio (higher pHIN) than gate 2, and gate 4 included all cells with a higher fluorescence intensity ratio (lower pHIN) than gate 3.

Antibiotic uptake assays.Antibiotic uptake assays were performed similarly to those previously described (47). Stock [3H]norfloxacin (31.3 mCi/mg [American Radiolabeled Chemicals]) was prepared by diluting labeled drug with unlabeled norfloxacin to specific activities of 9.8 mCi/mg for E. coli and 3.6 µCi/mg for S. aureus, and M. smegmatis. Working concentrations of 10 µg/ml for E. coli experiments and 100 µg/ml for S. aureus and M. smegmatis experiments were used. Stock [3H]vancomycin (0.133 mCi/mg [American Radiolabeled Chemicals]) was prepared by diluting labeled drug with unlabeled vancomycin to a specific activity of 0.011 mCi/mg and a working concentration of 1.0 mg/ml. Stock [3H]tetracycline (44 mCi/mg [American Radiolabeled Chemicals]) was prepared by diluting labeled drug with unlabeled tetracycline to a specific activity of 0.51 mCi/mg and a working concentration of 10 mg/ml. Cultures were started as described above. Stock solutions of [3H]norfloxacin, [3H]vancomycin, or [3H]tetracycline were added to achieve a final antibiotic concentration shown in Table 3. Aliquots of culture (450 µl) were removed at intervals, placed on GF/C filters (Whatman) while under vacuum filtration, and washed with 8 ml 0.85% NaCl. Filters were freeze-dried at −80°C. Radioactivity on filters was quantitated by scintillation counting. Three readings of all samples were recorded, and the average counts per minute was obtained. Nonspecific binding of 3H-labeled antibiotic to filters was determined by adding labeled antibiotic to cell-free medium and subjecting it to the same vacuum filtration and washing as experimental samples, which served as a negative control. Internalized antibiotic was calculated by subtracting the negative control from each sample. The counts from this sample were divided from the counts obtained by adding pure labeled antibiotic of a known concentration to a membrane without washing to obtain a concentration of antibiotic associated with cells. This antibiotic concentration was divided by the total cellular protein concentration for each sample to obtain a measurement of antibiotic per total protein.

To determine cellular protein concentration, non-radiolabeled norfloxacin, vancomycin, or tetracycline was added to cultures as described above, and aliquots were removed for protein content determination with a Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, CA). Four hundred-fifty-microliter samples were taken at the same time points used for radioactive analysis and subjected to centrifugation at 16,000 × g for 1.5 min, and supernatants were carefully discarded. Pellets were suspended in equal volumes of 1× phosphate-buffered saline and subjected to lysis via sonication. Supernatants were clarified by centrifugation, and 150 µl was used for total protein analysis as per the manufacturer’s protocol (Bio-Rad QuickStart Bradford assay) in duplicate. The values from the duplicate samples were averaged per time point per biological replicate. Each reported value represents the mean ± standard deviation from 3 biological replicates for norfloxacin and tetracycline experiments and 6 biological replicates for vancomycin experiments.

ATP quantification.ATP measurements were taken as previously described (48). After 1 h of treatment, cultures were pelleted, frozen on dry ice, and stored at −80°C until processed. Frozen cell pellets were suspended in 100 µl 0.025 M HEPES buffer with 0.02% Tween 80 (pH 7.75) and added to glass tubes (12 by 75 mm) containing 40 µl chloroform. Mixtures were then heated at 80°C for 20 min, and subsequently, 4.9 ml 0.025 M HEPES buffer (pH 7.75) was added. The ATP assay was performed as per the manufacturer’s protocol (Promega Enliten ATP assay system). Ten-microliter samples were added to a 96-well plate (Costar solid white) and loaded into an L-Max microplate luminometer (Molecular Devices). Enliten luciferase-luciferin reagent dissolved in sample buffer was injected immediately before the results were read. Luminescence was determined every 0.1 s for a total of 100 s. Data are the averages from 6 independent experiments assayed in duplicate.

Statistical analysis.The Colorado Biostatistics Consortium at the Colorado School of Public Health was consulted to determine appropriate statistical analytical methods. For all statistical analyses, a paired, one-tailed t test was performed. For flow cytometry analyses, all data points were compared to the control sample from the same experiment. For survival studies, all data points were compared to the mid-pH sample from the same experiment unless otherwise noted.

ACKNOWLEDGMENTS

We thank Sabine Ehrt for the gift of mycobacterial pH-sensitive GFP. We thank Alistaire Acosta, Karen Helm, Kristina Heide, and the University of Colorado Cancer Center Flow Cytometry Core for assistance with flow cytometry and the University of Colorado Biostatistics Consortium for assistance with statistical analysis.

This work was supported by NIH grant R01 AI061505 awarded to M.I.V. and Bill and Melinda Gates Foundation grant 1033596 awarded to A.J.L.

FOOTNOTES

    • Received June 24, 2016.
    • Accepted August 1, 2016.
  • Copyright © 2016 Bartek et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license .

REFERENCES

  1. 1.↵
    1. Balaban NQ,
    2. Merrin J,
    3. Chait R,
    4. Kowalik L,
    5. Leibler S
    . 2004. Bacterial persistence as a phenotypic switch. Science305:1622–1625. doi:10.1126/science.1099390.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Maisonneuve E,
    2. Gerdes K
    . 2014. Molecular mechanisms underlying bacterial persisters. Cell157:539–548. doi:10.1016/j.cell.2014.02.050.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Kohanski MA,
    2. Dwyer DJ,
    3. Hayete B,
    4. Lawrence CA,
    5. Collins JJ
    . 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell130:797–810. doi:10.1016/j.cell.2007.06.049.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Gusarov I,
    2. Shatalin K,
    3. Starodubtseva M,
    4. Nudler E
    . 2009. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science325:1380–1384. doi:10.1126/science.1175439.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Shatalin K,
    2. Shatalina E,
    3. Mironov A,
    4. Nudler E
    . 2011. H2S: a universal defense against antibiotics in bacteria. Science334:986–990. doi:10.1126/science.1209855.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Nandakumar M,
    2. Nathan C,
    3. Rhee KY
    . 2014. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat Commun5:4306. doi:10.1038/ncomms5306.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dwyer DJ,
    2. Belenky PA,
    3. Yang JH,
    4. MacDonald IC,
    5. Martell JD,
    6. Takahashi N,
    7. Chan CT,
    8. Lobritz MA,
    9. Braff D,
    10. Schwarz EG,
    11. Ye JD,
    12. Pati M,
    13. Vercruysse M,
    14. Ralifo PS,
    15. Allison KR,
    16. Khalil AS,
    17. Ting AY,
    18. Walker GC,
    19. Collins JJ
    . 2014. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci U S A111:E2100–E2109. doi:10.1073/pnas.1401876111.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Dörr T,
    2. Vulić M,
    3. Lewis K
    . 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol8:e1000317. doi:10.1371/journal.pbio.1000317.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Diez M,
    2. Zimmermann B,
    3. Börsch M,
    4. König M,
    5. Schweinberger E,
    6. Steigmiller S,
    7. Reuter R,
    8. Felekyan S,
    9. Kudryavtsev V,
    10. Seidel CA,
    11. Gräber P
    . 2004. Proton-powered subunit rotation in single membrane-bound F0F1-ATP synthase. Nat Struct Mol Biol11:135–141. doi:10.1038/nsmb718.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Mitchell P
    . 1961. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature191:144–148. doi:10.1038/191144a0.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Kohanski MA,
    2. Dwyer DJ,
    3. Collins JJ
    . 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol8:423–435. doi:10.1038/nrmicro2333.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Allison KR,
    2. Brynildsen MP,
    3. Collins JJ
    . 2011. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature473:216–220. doi:10.1038/nature10069.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Rao SP,
    2. Alonso S,
    3. Rand L,
    4. Dick T,
    5. Pethe K
    . 2008. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A105:11945–11950. doi:10.1073/pnas.0711697105.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Hattori T,
    2. Watanabe K,
    3. Uechi Y,
    4. Yoshioka H,
    5. Ohta Y
    . 2005. Repetitive transient depolarizations of the inner mitochondrial membrane induced by proton pumping. Biophys J88:2340–2349. doi:10.1529/biophysj.104.041483.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Cooper CE,
    2. Brown GC
    . 2008. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr40:533–539. doi:10.1007/s10863-008-9166-6.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Yano T,
    2. Li LS,
    3. Weinstein E,
    4. Teh JS,
    5. Rubin H
    . 2006. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). J Biol Chem281:11456–11463. doi:10.1074/jbc.M508844200.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Cook GM,
    2. Hards K,
    3. Vilchèze C,
    4. Hartman T,
    5. Berney M
    . 2014. Energetics of respiration and oxidative phosphorylation in mycobacteria. Microbiol Spectr doi:10.1128/microbiolspec.MGM2-0015-2013.
    OpenUrlCrossRef
  18. 18.↵
    1. Rao M,
    2. Streur TL,
    3. Aldwell FE,
    4. Cook GM
    . 2001. Intracellular pH regulation by Mycobacterium smegmatis and Mycobacterium bovis BCG. Microbiology147:1017–1024. doi:10.1099/00221287-147-4-1017.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Slonczewski JL,
    2. Rosen BP,
    3. Alger JR,
    4. Macnab RM
    . 1981. pH homeostasis in Escherichia coli: measurement by 31P nuclear magnetic resonance of methylphosphonate and phosphate. Proc Natl Acad Sci U S A78:6271–6275. doi:10.1073/pnas.78.10.6271.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Miesenböck G,
    2. De Angelis DA,
    3. Rothman JE
    . 1998. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature394:192–195. doi:10.1038/28190.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Pankey GA,
    2. Sabath LD
    . 2004. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis38:864–870. doi:10.1086/381972.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Levy SB
    . 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother36:695–703. doi:10.1128/AAC.36.4.695.
    OpenUrlFREE Full Text
  23. 23.↵
    1. Kourtesi C,
    2. Ball AR,
    3. Huang YY,
    4. Jachak SM,
    5. Vera DM,
    6. Khondkar P,
    7. Gibbons S,
    8. Hamblin MR,
    9. Tegos GP
    . 2013. Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J7:34–52. doi:10.2174/1874285801307010034.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Rodrigues L,
    2. Ramos J,
    3. Couto I,
    4. Amaral L,
    5. Viveiros M
    . 2011. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance. BMC Microbiol11:35. doi:10.1186/1471-2180-11-35.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Taber HW,
    2. Mueller JP,
    3. Miller PF,
    4. Arrow AS
    . 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol Res51:439–457.
    OpenUrl
  26. 26.↵
    1. Nikaido H
    . 1996. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol178:5853–5859.
    OpenUrlFREE Full Text
  27. 27.↵
    1. Black PA,
    2. Warren RM,
    3. Louw GE,
    4. van Helden PD,
    5. Victor TC,
    6. Kana BD
    . 2014. Energy metabolism and drug efflux in Mycobacterium tuberculosis. Antimicrob Agents Chemother58:2491–2503. doi:10.1128/AAC.02293-13.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Kaatz GW,
    2. Seo SM,
    3. Ruble CA
    . 1991. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J Infect Dis163:1080–1086. doi:10.1093/infdis/163.5.1080.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Li TK,
    2. Liu LF
    . 1998. Modulation of gyrase-mediated DNA cleavage and cell killing by ATP. Antimicrob Agents Chemother42:1022–1027.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Schneider DA,
    2. Gourse RL
    . 2004. Relationship between growth rate and ATP concentration in Escherichia coli: a bioassay for available cellular ATP. J Biol Chem279:8262–8268. doi:10.1074/jbc.M311996200.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Hughes J,
    2. Mellows G
    . 1978. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo)31:330–335. doi:10.7164/antibiotics.31.330.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Höjer H,
    2. Nilsson L
    . 1978. Rapid determination of doxycycline based on luciferase assay of bacterial adenosine triphosphate. J Antimicrob Chemother4:503–508. doi:10.1093/jac/4.6.503.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Padan E,
    2. Bibi E,
    3. Ito M,
    4. Krulwich TA
    . 2005. Alkaline pH homeostasis in bacteria: new insights. Biochim Biophys Acta1717:67–88. doi:10.1016/j.bbamem.2005.09.010.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Hoppe J,
    2. Sebald W
    . 1984. The proton conducting F0-part of bacterial ATP synthases. Biochim Biophys Acta768:1–27. doi:10.1016/0304-4173(84)90005-3.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Sebald W,
    2. Machleidt W,
    3. Wachter E
    . 1980. N,N′-dicyclohexylcarbodiimide binds specifically to a single glutamyl residue of the proteolipid subunit of the mitochondrial adenosinetriphosphatases from Neurospora crassa and Saccharomyces cerevisiae. Proc Natl Acad Sci U S A77:785–789. doi:10.1073/pnas.77.2.785.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Li XZ,
    2. Zhang L,
    3. Nikaido H
    . 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother48:2415–2423. doi:10.1128/AAC.48.7.2415-2423.2004.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Lobritz MA,
    2. Belenky P,
    3. Porter CB,
    4. Gutierrez A,
    5. Yang JH,
    6. Schwarz EG,
    7. Dwyer DJ,
    8. Khalil AS,
    9. Collins JJ
    . 2015. Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A112:8173–8180. doi:10.1073/pnas.1509743112.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Nakamoto T,
    2. Wakahara S
    . 2004. Development of substrate induced respiration (SIR) method combined with selective inhibition for estimating fungal and bacterial biomass in humic andosols. Plant Prod Sci7:70–76. doi:10.1626/pps.7.70.
    OpenUrlCrossRef
  39. 39.↵
    1. Dwyer DJ,
    2. Collins JJ,
    3. Walker GC
    . 2015. Unraveling the physiological complexities of antibiotic lethality. Annu Rev Pharmacol Toxicol55:313–332. doi:10.1146/annurev-pharmtox-010814-124712.
    OpenUrlCrossRef
  40. 40.↵
    1. Liu Y,
    2. Imlay JA
    . 2013. Cell death from antibiotics without the involvement of reactive oxygen species. Science339:1210–1213. doi:10.1126/science.1232751.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Keren I,
    2. Wu Y,
    3. Inocencio J,
    4. Mulcahy LR,
    5. Lewis K
    . 2013. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science339:1213–1216. doi:10.1126/science.1232688.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Bäuerlein E,
    2. Keihl R
    . 1976. Lipophilic thiourea and thiouracil as inhibitors of oxidative phosphorylation. FEBS Lett61:68–71. doi:10.1016/0014-5793(76)80173-1.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Oexle H,
    2. Gnaiger E,
    3. Weiss G
    . 1999. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta1413:99–107. doi:10.1016/S0005-2728(99)00088-2.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Unciti-Broceta A,
    2. Rahimi Yusop M,
    3. Richardson PR,
    4. Walton JGA,
    5. Bradley M
    . 2009. A fluorescein-derived anthocyanidin-inspired pH sensor. Tetrahedron Lett50:3713–3715. doi:10.1016/j.tetlet.2009.03.223.
    OpenUrlCrossRef
  45. 45.↵
    1. Lu P,
    2. Heineke MH,
    3. Koul A,
    4. Andries K,
    5. Cook GM,
    6. Lill H,
    7. van Spanning R,
    8. Bald D
    . 2015. The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress. Sci Rep5:10333. doi:10.1038/srep10333.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Vandal OH,
    2. Pierini LM,
    3. Schnappinger D,
    4. Nathan CF,
    5. Ehrt S
    . 2008. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med14:849–854. doi:10.1038/nm.1795.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Cohen SP,
    2. Mcmurry LM,
    3. Hooper DC,
    4. Wolfson JS,
    5. Levy SB
    . 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coliselected by tetracycline or chloramphenicol—decreased drug accumulation associated with membrane changes in addition to Ompf reduction. Antimicrob Agents Chemother33:1318–1325. doi:10.1128/AAC.33.8.1318.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Leistikow RL,
    2. Morton RA,
    3. Bartek IL,
    4. Frimpong I,
    5. Wagner K,
    6. Voskuil MI
    . 2010. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol192:1662–1670. doi:10.1128/JB.00926-09.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis
I. L. Bartek, M. J. Reichlen, R. W. Honaker, R. L. Leistikow, E. T. Clambey, M. S. Scobey, A. B. Hinds, S. E. Born, C. R. Covey, M. J. Schurr, A. J. Lenaerts, M. I. Voskuil
mSphere Aug 2016, 1 (4) e00176-16; DOI: 10.1128/mSphere.00176-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis
I. L. Bartek, M. J. Reichlen, R. W. Honaker, R. L. Leistikow, E. T. Clambey, M. S. Scobey, A. B. Hinds, S. E. Born, C. R. Covey, M. J. Schurr, A. J. Lenaerts, M. I. Voskuil
mSphere Aug 2016, 1 (4) e00176-16; DOI: 10.1128/mSphere.00176-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antibiotics
bactericidal activity
mycobacteria
pH homeostasis

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042